医学
骨质疏松症
妇科癌症
癌症
子宫内膜癌
卵巢切除术
妇科
子宫癌
健骨
物理疗法
肿瘤科
产科
内科学
卵巢癌
外科
子宫切除术
骨矿物
作者
Janelle Sobecki,Laurel W. Rice,Ellen M. Hartenbach
标识
DOI:10.1016/j.ygyno.2020.11.028
摘要
Cancer treatment-induced bone loss is a known side effect of cancer therapy that increases the risk of osteoporosis and bone fracture. Women with gynecologic cancer are at increased risk of bone loss secondary to the combined effect of oophorectomy and adjuvant therapies. Data regarding bone loss in women with gynecologic cancers are overall lacking compared to other cancer populations. Consequently, guidelines for osteoporosis screening in women with cancer are largely based on data generated among non-gynecologic cancer survivors. This article reviews current available data of bone health in women with gynecologic cancer, summarizes best-available guidelines for screening for osteoporosis in women with cancer, and provides guidance for osteoporosis screening in women with gynecologic cancers based on best available evidence.
科研通智能强力驱动
Strongly Powered by AbleSci AI